Evidence map›Paper›PMID 29875196›Full record

ArticleJournal of clinical microbiology2018

Malaria Diagnostic Practices in U.S. Laboratories in 2017.

Christopher Prestel, Kathrine R Tan, Francisca Abanyie, Robert Jerris, Julie R Gutman

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. CDC Operational Guidance for Investigating Locally Acquired Mosquito-Transmitted Malaria - United States, 2026.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Malaria Surveillance - United States, 2018.Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) · 2022
    Article
  6. Article
  7. Malaria Surveillance - United States, 2017.Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002) · 2021
    Article
  8. Evaluation of the sick returned traveler.Seminars in diagnostic pathology · 2019
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Christopher PrestelDivision of Pediatric Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA csprestel@gmail.com.
Kathrine R TanDivision of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
Francisca AbanyieDivision of Healthcare Quality and Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.
Robert JerrisEmory University School of Medicine, Department of Pathology and Laboratory Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Julie R GutmanDivision of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the United States, the gold standard for malaria diagnosis is microscopic blood smear examination. Because malaria is not endemic in the United States, diagnostic capabilities may be limited, causing delays in diagnosis and increased morbidity and mortality. A survey of the malaria diagnostic practices of U.S. laboratories was conducted from June to July 2017; members of the American Society for Microbiology's listserv received a questionnaire inquiring about malaria diagnostic test availability, techniques, and reporting. Results were assessed using the Clinical and Laboratory Standards Institute (CLSI) guidelines for malaria diagnostics. After excluding incomplete and duplicate responses, responses representing 175 laboratories were included. Most labs (99%) received at least one specimen annually for malaria diagnosis, and 31% reported receiving only 1 to 10 specimens. The majority (74%) diagnosed five or fewer cases of malaria per year. Most (90%) performed blood smears on-site. Two-thirds (70%) provided initial blood smear results within 4 h. Although diagnostic testing for malaria was available 24/7 at 74% (141) of responding laboratories, only 12% (17) met criteria for analysis and reporting of malaria testing, significantly more than reported in a similar survey in 2010 (3%;

Indexed as

Clinical Laboratory ServicesClinical Laboratory TechniquesDiagnostic Tests, RoutineDisease NotificationGuideline AdherenceHumansLaboratoriesMalariaSurveys and QuestionnairesUnited StatesCLSI guidelinesdiagnostic testingmalariaUnited States

Identifiers

PMID29875196
PMCPMC6062816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.